6
Feb 2026
Why “low testosterone” has become a profitable masculinity crisis online
Social media's portrayal of low testosterone transforms masculinity into a marketable issue, linking health interventions to male identity and performance.
Stay Informed!
6
Feb 2026
Climate change is accelerating antibiotic resistance across the Western Pacific
Urgent action is needed as climate change fuels antibiotic resistance in the Western Pacific, threatening health and highlighting socioeconomic vulnerabilities.
6
Feb 2026
Health harms from plastics could double by 2040
Global health burdens associated with plastic systems could double by 2040 without immediate and coordinated action.
5
Feb 2026
Preoperative factors predict persistent opioid use after surgery
For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication.
5
Feb 2026
Brain connectivity fingerprints differ in major depressive disorder
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve diagnosis and treatment.
5
Feb 2026
Hormonal contraceptives show differing heart risks among stressed women
Antonia Seligowski, PhD, of the Neurocardiac Effects of Stress & Trauma Laboratory within the Department of Psychiatry at Mass General Brigham, is the senior author of a paper published in JAMA Network Open, "Hormonal contraceptive use, stress disorders, and cardiovascular and thrombotic risk in women."
5
Feb 2026
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026
Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows.
5
Feb 2026
Early biomarkers predict infections after breast reconstruction surgery
In the U.S., one in eight women will get breast cancer in their lifetime, and about half of them will have mastectomies.
5
Feb 2026
Computational method clarifies microbial signals in tumor sequencing
When scientists sequence tumor DNA, they typically find small amounts of genetic code from bacteria, viruses and fungi – microorganisms that, if actually present in tumor tissues, could influence how they grow, evade immunity or respond to treatment.
5
Feb 2026
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.
